Skip to main content

Corteva, Inc.

For the period ended Jun 30, 2026. Filed Jul 31, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Jul 31, 2026

CTVA$12.11+1.8%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Revenue

NOTE 3 -REVENUE

Remaining Performance Obligations

Remaining performance obligations represent the transaction price allocated to unsatisfied or partially unsatisfied performance obligations. The company applies the practical expedient to disclose the transaction price allocated to the remaining performance obligations for only those contracts with an original duration of more than one year. The transaction price allocated to remaining performance obligations with an original duration of more than one year related to material rights granted to customers for contract renewal options were $155 million, $150 million and $141 million at June 30, 2026, December 31, 2025 and June 30, 2025, respectively. The company expects revenue to be recognized for the remaining performance obligations evenly over a period ofsix years.

Contract Balances

Contract liabilities primarily reflect deferred revenue from prepayments under contracts with customers where the company receives advance payments for products to be delivered in future periods. Corteva classifies deferred revenue as current or noncurrent based on the timing of when the company expects to recognize revenue. Contract assets primarily include amounts related to conditional rights to consideration for completed performance not yet invoiced. Accounts receivable are recorded when the right to consideration becomes unconditional.

Contract BalancesJune 30, 2026December 31, 2025June 30, 2025
(In millions)
Contract assets - current 1$35$34$31
Contract assets - noncurrent 2$88$83$77
Deferred revenue - current$383$3,579$358
Deferred revenue - noncurrent 3$119$125$118
  1. Included in other current assets in the interim Consolidated Balance Sheets.

  2. Included in other assets in the interim Consolidated Balance Sheets.

  3. Included in other noncurrent obligations in the interim Consolidated Balance Sheets.

Revenue recognized during the six months ended June 30, 2026 and 2025 from amounts included in deferred revenue at the beginning of the period was $3,308 million and $3,091 million, respectively.

Disaggregation of Revenue

Corteva's operations are classified intotwo operating segments: Seed and Crop Protection. The company disaggregates its revenue by major product line and geographic region, as the company believes it best depicts the nature, amount and timing of its revenue and cash flows. Net sales by major product line are included below:

Three Months Ended June 30,Six Months Ended June 30,
(In millions)2026202520262025
Corn$2,868$2,961$5,241$5,030
Soybean1,3181,2571,6241,562
Other oilseeds228186473409
Other118133217243
Seed4,5324,5377,5557,244
Herbicides9329951,9591,855
Insecticides399436776772
Fungicides263342597646
Biologicals8697156181
Other16749241175
Crop Protection1,8471,9193,7293,629
Total$6,379$6,456$11,284$10,873

Sales are attributed to geographic regions based on customer location. Net sales by geographic region and segment are included below:

SeedThree Months Ended June 30,Six Months Ended June 30,
(In millions)2026202520262025
North America 1$3,955$3,954$5,725$5,551
EMEA 22722821,2001,108
Latin America160154384339
Asia Pacific145147246246
Total$4,532$4,537$7,555$7,244
Crop ProtectionThree Months Ended June 30,Six Months Ended June 30,
(In millions)2026202520262025
North America 1$593$675$1,262$1,288
EMEA 24584651,1851,116
Latin America519518801775
Asia Pacific277261481450
Total$1,847$1,919$3,729$3,629
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.